Global Top 10 Player
in Microbiome
Therapeutics
Leading Company in the Development of New Microbiome Drugs
KoBioLabs
ABOUT US
KoBioLabs is recognized for its international level of microbiome therapeutic technologies.
In particular, our researchers have a distinctive position in the microbiology field globally
with their presence in the ongoing International Human Microbiome Consortium [IHMC].
Microbiome is a compound word of Microbiota and Genome, meaning "microbiota and symbiotic microorganisms in the human body"
The human microbiome is also called as 'second genome' due to its vast number of cells (~39 trillion) and highly correlated with human health.
Microbiome is widely used in the development of new drugs and the study of incurable disease treatments, and also can be applied in various business fields such as food and cosmetics.
Reliable & High
Quality Laboratory
KoBioLabs can do the best for actualization the high level of research achievements by best experts in the relevant field as a society's valuable asset.
A happy place of life for employees
Develop products for healthy and happy life for customers
Best efforts for high return on investments for investors
MEDIA CENTER
Press and Release
